ACR-246

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameACR-246
Drug Alias NameACR246ACR-246ADC2154ADC-2154
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionTrophoblast glycoprotein modulators
TargetsTrophoblast glycoprotein
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsUterine Cervical Neoplasms +[10
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic NeoplasmsUterine Cervical Neoplasms +[10
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A